Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Antibodies > Research Grade Biosimilars

Anti-Human ErbB2/Her2 Reference Antibody (Trastuzumab, RUO) (HY286016)

Anti-Human ErbB2/Her2 Reference Antibody (Trastuzumab, RUO)
Anti-Human ErbB2/Her2 Reference Antibody (Trastuzumab, RUO)
Anti-Human ErbB2/Her2 Reference Antibody (Trastuzumab, RUO)
Anti-Human ErbB2/Her2 Reference Antibody (Trastuzumab, RUO)
Anti-Human ErbB2/Her2 Reference Antibody (Trastuzumab, RUO)
Anti-Human ErbB2/Her2 Reference Antibody (Trastuzumab, RUO)
Price(USD):
Spec:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
Number:
Get quote
  • Overview

  • Images

  • References

  • Datasheet

  • SDS

Overview
Catalog No.HY286016
Description
Trastuzumab (HY286016) is a research-grade recombinant antibody targeting CD340. Produced in mammalian cells with native-like glycosylation.
Highlights
  • Research Grade — For PK/PD studies, assay development, and ADA research.
  • Native Glycosylation — Mammalian expression ensures native-like patterns.
Species reactivityHuman
ApplicationsELISA, Bioactivity: FACS, Functional assay, Research in vivo
Host speciesHuman
IsotypeIgG1-kappa
Expression system Mammalian cells
Clonality Monoclonal
Target p185erbB2, HER2, NGL, Tyrosine kinase-type cell surface receptor HER2, NEU, MLN 19, Proto-oncogene Neu, MLN19, ERBB2, Proto-oncogene c-ErbB-2, CD340, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
Accession P04626
Form Liquid
Storage buffer 0.01M PBS pH 7.4

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Stability and Storage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternate Namestimigutuzumab, 4D5-8, 4D5V8, Herceptin, rhuMabHER2, 180288-69-1
Background

Receptor tyrosine-protein kinase erbB-2 (CD340/ERBB2) is a ~137 kDa protein. Protein tyrosine kinase that is part of several cell surface receptor complexes, but that apparently needs a coreceptor for ligand binding. Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Regulates outgrowth and stabilization of peripheral microtubules (MTs). Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell membrane. CD340 is the therapeutic target of trastuzumab (Herceptin) and trastuzumab deruxtecan (Enhertu).

Note For research use only. Not suitable for clinical or therapeutic use.
Images
  • Anti-Human ErbB2/Her2 Reference Antibody (Trastuzumab, RUO)

    Bioactivity

    Detects Human ERBB2 in indirect ELISAs.

  • Anti-Human ErbB2/Her2 Reference Antibody (Trastuzumab, RUO)

    SDS-PAGE

    SDS-PAGE for Research Grade Trastuzumab.

  • Anti-Human ErbB2/Her2 Reference Antibody (Trastuzumab, RUO)

    HPLC

    SEC-HPLC detection for Research Grade Trastuzumab.

Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: support@abinScience.com

Distributor list